Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 745-752

  Hukkanen, Janne ^a,b   Väisänen, Teemu ^a   Lassila, Arja ^a   Piipari, Ritva ^c   Anttila, Sisko ^c   Pelkonen, Olavi ^a   Raunio, Hannu ^d   Hakkola, Jukka ^a  

^a UNIVERSITY OF OULU   (Finland)

^b LAPLAND CENTRAL HOSPITAL   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CIGARETTE SMOKE; CLOTRIMAZOLE; CYTOCHROME P450 3A5; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; NIFEDIPINE; RIFAMPICIN;

ARTICLE; ASTHMA; CANCER CELL CULTURE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOCHROME P-450 ENZYME SYSTEM; GLUCOCORTICOIDS; HUMANS; LUNG; MACROPHAGES, ALVEOLAR; RESPIRATORY MUCOSA; RNA, MESSENGER; SMOKING; TUMOR CELLS, CULTURED;

EID: 0037308012     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.038208     Document Type: Article

References (33)

1. Anttila S, Hietanen E, Vainio H, Camus AM, Gelboin HV, Park SS, Heikkila L, Karjalainen A, and Bartsch H (1991) Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer 47:681-685.
2. Anttila S, Hukkanen J, Hakkola J, Stjernvall T, Beaune P, Edwards RJ, Boobis AR, Pelkonen O, and Raunio H (1997) Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell Mol Biol 16:242-249.
3. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al. (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 264:10388-10395.
4. Autrup H (1990) Carcinogen metabolism in cultured human tissues and cells. Carcinogenesis 11:707-712.
5. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, and Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobaccorelated cancers. Cancer Epidemiol Biomarkers Prev 9:3-28.
6. Boobis AR (1998) Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide. Respir Med 92 (Suppl B):2-6.
7. Cadepond F, Ulmann A, and Baulieu EE (1997) RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 48:129-156.
8. Denissenko MF, Pao A, Tang M, and Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science (Wash DC) 274:430-432.
9. Esmailpour N, Hogger P, and Rohdewald P (1998) Binding kinetics of budesonide to the human glucocorticoid receptor. Eur J Pharm Sci 6:219-223.
10. Finta C and Zaphiropoulos PG (2000) The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene (Amst) 260:13-23.
11. Hakkola J, Raunio H, Purkunen R, Saarikoski S, Vahakangas K, Pelkonen O, Edwards RJ, Boobis AR, and Pasanen M (2001) Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate 80:193-201.
12. Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210.
13. Hukkanen J, Lassila A, Paivarinta K, Valanne S, Sarpo S, Hakkola J, Pelkonen O, and Raunio H (2000) Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 22:360-366.
14. Jonsson G, Astrom A, and Andersson P (1995) Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab Dispos 23:137-142.
15. Jounaidi Y, Guzelian PS, Maurel P, and Vilarem MJ (1994) Sequence of the 5′flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem Biophys Res Commun 205:1741-1747.
16. Kawajiri K (1999) Metabolic polymorphism and susceptibility to cancer (Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, and Boffetta P, eds) vol 148, pp 159-172. IARC Scientific Publications, Lyon, France.
17. Kivisto KT, Fritz P, Linder A, Friedel G, Beaune P, and Kroemer HK (1995) Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem Cell Biol 103:25-29.
18. Kivisto KT, Griese EU, Fritz P, Linder A, Hakkola J, Raunio H, Beaune P, and Kroemer HK (1996) Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours. Naunyn-Schmiedeberg's Arch Pharmacol 353:207-212.
19. Kocarek TA, Schuetz EG, Strom SC, Fisher RA, and Guzelian PS (1995) Comparative analysis of cytochrome P4503A induction in primary cultures ofrat, rabbit and human hepatocytes. Drug Metab Dispos 23:415-421.
20. Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC, and Pfeifer AM (1998) Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 34:914-920.
21. McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, et al. (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333-1339.
22. Moilanen AM, Poukka H, Karvonen U, Hakli M, Janne OA, and Palvimo JJ (1998) Identification of a novel RING finger protein as a coregulator in steroid receptormediated gene transcription. Mol Cell Biol 18:5128-5139.
23. Pascussi JM, Drocourt L, Gerbal-Chaloin S, Fabre JM, Maurel P, and Vilarem MJ (2001) Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 268:6346-6358.
24. Piipari R, Savela K, Nurminen T, Hukkanen J, Raunio H, Hakkola J, Mantyla T, Beaune P, Edwards RJ, Boobis AR, et al. (2000) Expression of CYP1A1, CYP1B1 and CYP3A and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int J Cancer 86:610-616.
25. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, and Pelkonen O (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review. Gene (Amst) 159:113-121.
26. Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FF, and Holder GM (1993) The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen. Biochem Biophys Res Commun 192:1373-1379.
27. Schuetz JD, Schuetz EG, Thottassery JV, Guzelian PS, Strom S, and Sun D (1996) Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol 49:63-72.
28. Shimada T, Martin MV, Pruess-Schwartz D, Marnett LJ, and Guengerich FP (1989) Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo[a]pyrene, 7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res 49:6304-6312.
29. Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH, and Guengerich FP (1992) Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41:856-864.
30. Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, and Gelboin HV (1994) The role of 12 cDNA-expressed human, rodent and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7, 8-dihydrodiol. Mol Carcinog 10:159-168.
31. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, and Korzekwa K (1991) Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 290:160-166.
32. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, and Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213.
33. Yamazaki H, Inui Y, Wrighton SA, Guengerich FP, and Shimada T (1995) Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis 16:2167-2170.